Business Description
Crinetics Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US22663K1079
Description
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.8 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | -0.23 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 19.13 | |||||
| Beneish M-Score | 0.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -16.2 | |||||
| 3-Year EPS without NRI Growth Rate | -15.1 | |||||
| 3-Year FCF Growth Rate | -13 | |||||
| 3-Year Book Growth Rate | 15.6 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 28.95 | |||||
| 9-Day RSI | 37.6 | |||||
| 14-Day RSI | 43.48 | |||||
| 6-1 Month Momentum % | 48.43 | |||||
| 12-1 Month Momentum % | 132.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.07 | |||||
| Quick Ratio | 13.07 | |||||
| Cash Ratio | 12.71 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.4 | |||||
| Shareholder Yield % | -0.73 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -5547.17 | |||||
| Net Margin % | -5345.85 | |||||
| FCF Margin % | -4261.03 | |||||
| ROE % | -55.36 | |||||
| ROA % | -47.96 | |||||
| ROIC % | -495.84 | |||||
| ROC (Joel Greenblatt) % | -860.59 | |||||
| ROCE % | -53.89 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 569.19 | |||||
| PB Ratio | 5.33 | |||||
| Price-to-Tangible-Book | 5.32 | |||||
| EV-to-EBIT | -12.62 | |||||
| EV-to-EBITDA | -12.69 | |||||
| EV-to-Revenue | 700.2 | |||||
| EV-to-Forward-Revenue | 1123.95 | |||||
| EV-to-FCF | -16.43 | |||||
| Price-to-Net-Current-Asset-Value | 6.01 | |||||
| Price-to-Net-Cash | 6.21 | |||||
| Earnings Yield (Greenblatt) % | -7.92 | |||||
| FCF Yield % | -5.16 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CRNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Crinetics Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 4.013 | ||
| EPS (TTM) ($) | -3.7 | ||
| Beta | 0.13 | ||
| Volatility % | 75.91 | ||
| 14-Day RSI | 43.48 | ||
| 14-Day ATR ($) | 2.188951 | ||
| 20-Day SMA ($) | 44.9375 | ||
| 12-1 Month Momentum % | 132.42 | ||
| 52-Week Range ($) | 15.76 - 49.5799 | ||
| Shares Outstanding (Mil) | 78.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Crinetics Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Crinetics Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Crinetics Pharmaceuticals Inc Frequently Asked Questions
What is Crinetics Pharmaceuticals Inc(CRNX)'s stock price today?
The current price of CRNX is $42.12. The 52 week high of CRNX is $49.58 and 52 week low is $15.76.
When is next earnings date of Crinetics Pharmaceuticals Inc(CRNX)?
The next earnings date of Crinetics Pharmaceuticals Inc(CRNX) is 2024-05-03 Est..
Does Crinetics Pharmaceuticals Inc(CRNX) pay dividends? If so, how much?
Crinetics Pharmaceuticals Inc(CRNX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers